Nuvectis Pharma, Inc. (NVCT) stock
NVCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.11−1.13 (-5.58%)
Close on Nov 16, 2026Market cap $622.63MP/E –Yield 0.00%
Nuvectis Pharma gross margin
Gross margin is gross profit as a percentage of revenue.
No gross margin figures for Nuvectis Pharma
Nuvectis Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?